If you didn’t attend the Trading Places workshop at the LES Spring Meeting, you missed a unique perspective on deal-making. Ruth Plager, President of ZenithBio, organized a great panel of business development professionals who have worked on both sides of the table – large pharma/large biotech and small biotech companies. Different perspectives were shared by the panel members which included Michael Yeomans, PhD, ex- SVP of Global Business Development at Bayer, now President of Partners in Pharma, Jeff Jonker, Esq., CBO of Satori Pharma, ex-Gloucester (now Celgene) and ex-Genentech, Bradley Campbell, ex-Genzyme and now SVP, Business Operations at Amicus Therapeutics, and Carolyn Green, Founder & COO of Logical Therapeutics, ex-Founding Director, Office of Enterprise Development, University of Pittsburgh Health System.
May 31, 2011
LES Member Price:$0.00